TEV-56278
TV56278-ONC-10203
Phase 1 small_molecule active
Quick answer
TEV-56278 for Advanced Solid Tumors is a Phase 1 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active